Takeshi Kitano

Prof. Takeshi Kitano

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2010 in Molecular Reproduction and Development
Verified
Journal Article
Closed access
PDF file
YHYuki Hayashi
Yuki Hayashi
HKHiroshi Kobira
Hiroshi Kobira
TYToshiya Yamaguchi
Toshiya Yamaguchi
ESEri Shiraishi
Eri Shiraishi
TYTakashi Yazawa
Takashi Yazawa
TKTakeshi Kitano
Takeshi Kitano

7 August 2012 in Molecular Reproduction and Development
Verified
Journal Article
Closed access
PDF file
TKTakeshi Kitano
Takeshi Kitano
YHYuki Hayashi
Yuki Hayashi
ESEri Shiraishi
Eri Shiraishi
YKYasuhiro Kamei
Yasuhiro Kamei

1 August 2014 in Endocrinology
Verified
Journal Article
Closed access
NMNorikazu Murozumi
Norikazu Murozumi
RNRyo Nakashima
Ryo Nakashima
THToshiaki Hirai
Toshiaki Hirai
YKYasuhiro Kamei
Yasuhiro Kamei
TITomoko Ishikawa-Fujiwara
Tomoko Ishikawa-Fujiwara
TKTakeshi Kitano
Takeshi Kitano
FSH, a glycoprotein hormone, is circulated from the pituitary and functions by binding to a specific FSH receptor (FSHR). FSHR is a G protein-coupled, seven-transmembrane receptor linked to the adenylyl cyclase or other pathways and is expressed in gonadal somatic cells. In some nonmammalian species, fshr expression is much higher in the ovary than in the testis during gonadal sex differentiation, suggesting that FSHR is involved in ovarian development in nonmammalian vertebrates. However, little is known of FSHR knockout phenotypes in these species. Here we screened for fshr mutations by a medaka (Oryzias latipes) target-induced local lesion in the genomes and identified one nonsense mutation located in the BXXBB motif, which is involved in G protein activation. Next, we used an in vitro reporter gene assay to demonstrate that this mutation prevents FSHR function. We then analyzed the phenotypes of fshr mutant medaka. The fshr mutant male medaka displayed normal testes and were fertile, whereas the mutant female fish displayed small ovaries and were infertile because vitellogenesis was inhibited. The mutant females also have suppressed expression of ovary-type aromatase (cyp19a1a), a steroidogenic enzyme responsible for the conversion of androgens to estrogens, resulting in decreased 17β-estradiol levels. Moreover, loss of FSHR function caused female-to-male sex reversal in some cases. In addition, the transgenic overexpression of fshr in fshr mutants rescued FSHR function. These findings strongly suggest that in the medaka, FSH regulates the ovarian development and the maintenance mainly by the elevation of estrogen levels. We present the first FSHR knockout phenotype in a nonmammalian species.

26 November 2009 in Development, Growth & Differentiation
Verified
Journal Article
Closed access
PDF file
TDTomonori Deguchi
Tomonori Deguchi
MIMariko Itoh
Mariko Itoh
HUHiroko Urawa
Hiroko Urawa
TMTomohiro Matsumoto
Tomohiro Matsumoto
SNSohei Nakayama
Sohei Nakayama
YKYasuhiro Kamei
Yasuhiro Kamei

27 December 2007 in Endocrinology
Verified
Journal Article
Closed access
ESEri Shiraishi
Eri Shiraishi
NYNorifumi Yoshinaga
Norifumi Yoshinaga
TMTakeshi Miura
Takeshi Miura
HYHayato Yokoi
Hayato Yokoi
YWYuko Wakamatsu
Yuko Wakamatsu
TKTakeshi Kitano
Takeshi Kitano
Müllerian inhibiting substance (MIS) is a glycoprotein belonging to the TGF-β superfamily. In mammals, MIS is responsible for the regression of Müllerian ducts in the male fetus. However, the role of MIS in gonadal sex differentiation of teleost fish, which have no Müllerian ducts, has yet to be clarified. In the present study, we examined the expression pattern of mis and mis type 2 receptor (misr2) mRNAs and the function of MIS signaling in early gonadal differentiation in medaka (teleost, Oryzias latipes). In situ hybridization showed that both mis and misr2 mRNAs were expressed in the somatic cells surrounding the germ cells of both sexes during early sex differentiation. Loss-of-function of either MIS or MIS type II receptor (MISRII) in medaka resulted in suppression of germ cell proliferation during sex differentiation. These results were supported by cell proliferation assay using 5-bromo-2′-deoxyuridine labeling analysis. Treatment of tissue fragments containing germ cells with recombinant eel MIS significantly induced germ cell proliferation in both sexes compared with the untreated control. On the other hand, culture of tissue fragments from the MIS- or MISRII-defective embryos inhibited proliferation of germ cells in both sexes. Moreover, treatment with recombinant eel MIS in the MIS-defective embryos dose-dependently increased germ cell number in both sexes, whereas in the MISRII-defective embryos, it did not permit proliferation of germ cells. These results suggest that in medaka, MIS indirectly stimulates germ cell proliferation through MISRII, expressed in the somatic cells immediately after they reach the gonadal primordium.

27 June 2007 in Molecular Reproduction and Development
Verified
Journal Article
Closed access
PDF file
TKTakeshi Kitano
Takeshi Kitano
NYNorifumi Yoshinaga
Norifumi Yoshinaga
ESEri Shiraishi
Eri Shiraishi
TKTakashi Koyanagi
Takashi Koyanagi
SAShin‐Ichi Abe
Shin‐Ichi Abe